GlassScriptPhysician profile
Zackary Burrow
NPI 1902339732
$16,891.44
in general payments reported to CMS, 2019-2025
16 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,833 · 2020: $1,533 · 2021: $691 · 2022: $465 · 2023: $5,256 · 2024: $2,871 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,832 · Food and Beverage: $3,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,832.15 |
| Food and Beverage | $3,536.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $7,082.44 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $4,427.46 | 2021-2025 | Arcos, Rosa, Persona |
| Ortho Development Corporation | $2,126.59 | 2023 | |
| Stryker Corporation | $1,796.00 | 2020-2024 | Mako, Tornier Perform Reversed Glenoid |
| Axogen | $590.68 | 2021-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Total Joint Orthopedics, INC. | $266.98 | 2024 | |
| Smith+Nephew, INC. | $162.58 | 2019-2025 | Evos |
| Orthalign INC | $143.19 | 2023-2024 | Orthalign Plus |
| Restor3d, INC. | $93.72 | 2024 | |
| Skeletal Dynamics INC | $44.94 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $42.68 | 2025 | |
| Ferring Pharmaceuticals INC. | $30.52 | 2022-2025 | Euflexxa |
| Acera Surgical, INC. | $26.47 | 2022-2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $25.54 | 2024 | Va-Lcp |
| Bioventus LLC | $19.17 | 2025 | Durolane |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zackary Burrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.